标题 |
Rituximab (RTX), methotrexate (MTX) and temozolomide is a safe option for patients with primary central nervous system lymphoma (PCNSL) and post transplant lymphoproliferative disease (PTLD)
利妥昔单抗(RTX)、甲氨蝶呤(MTX)和替莫唑胺是原发性中枢神经系统淋巴瘤(PCNSL)和移植后淋巴增生性疾病(PTLD)患者的安全选择
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | Feitosa Ribeiro A, Fleury Perini G, Helman R, Bley Nascimento C, Kutner J, Souza Santos F, et al. Rituximab (RTX), methotrexate (MTX) and temozolomide is a safe option for patients with primary central nervous system lymphoma (PCNSL) and post transplant lymphoproliferative disease (PTLD). Haematologica 2011,96:572. |
求助人 | |
下载 | 暂无链接,等待应助者上传 |